🟢 Schrodinger is trading 9% up today after second-quarter results beat expectations

Schrodinger is trading 9% up at $18.07 after its August 5, 2026, second-quarter results exceeded expectations.

• Revenue reached $58.9 million, net income swung to $6.0 million, and adjusted earnings were $0.08 per share versus an expected loss.
• Management maintained ACV guidance at $218 million–$228 million and raised drug-discovery revenue guidance to $65 million–$75 million.
• Shares gained 4.79% to $16.40 on August 5; an expanded Bristol Myers Squibb AI co-scientist collaboration reinforced the software-platform narrative.